News & Updates
Showing Endocrinology articles
Showing

Vitamin D deficiency tied to higher T2D risk
Increased serum concentration of 25(OH)D appears to contribute to a reduced risk of type 2 diabetes (T2D) across the glycaemic spectrum below the threshold for diabetes, reports a study. Improving the lipid profile may be partly responsible for the favourable association.

SGLT-2 inhibitors may prevent dementia in adults with T2D
Initiation of sodium-glucose cotransporter-2 (SGLT-2) inhibitors results in a 35-percent reduced risk of dementia compared with dipeptidyl peptidase-4 (DPP-4) inhibitors in individuals with type 2 diabetes (T2D) aged 40–69 years, according to a study. In addition, greater benefits are seen with longer treatment duration.

Paediatric T2DM: Prevalence of microalbuminuria doubles within 2 years of diagnosis
Data from the Hong Kong Childhood Diabetes Registry (HKCDR) show that 2 years after diagnosis of paediatric type 2 diabetes mellitus (T2DM), approximately 20–65 percent of patients have ≥1 of the following: microalbuminuria (MA), suboptimal glycaemic control, hypertension, or dyslipidaemia.





